ÌÇÐÄvlog

This meta-analysis examines disparities in the inclusion of racial and ethnic minority groups and older adults across prostate cancer clinical trials.

This cross-sectional study uses results from the National COVID Cancer Antibody Survey to evaluate whether spike protein antibody vaccine response following COVID-19 vaccination is associated with risk of SARS-CoV-2 breakthrough infection or hospitalization among patients with cancer in the UK.

This subgroup analysis of a randomized clinical trial investigates whether tucatinib in combination with trastuzumab and capecitabine provides survival and intracranial benefits for patients with ERBB2-positive metastatic breast cancer and brain metastases.

This cross-sectional study examines the association between medical marijuana legalization and differences in opioid-related and pain-related outcomes in adults with newly diagnosed cancer who are undergoing anticancer treatment.

This meta-analysis examines whether immunotherapy confers a survival benefit for patients with advanced esophageal squamous cell carcinoma and low expression of PD-L1.

This diagnostic study determines whether the Ovarian-Adnexal Reporting and Data System (O-RADS) lexicon and the International Ovarian Tumor Analysis (IOTA) 2-step strategy can be used to stratify patients into risk groups.

This cohort study assesses whether a protocol restricting postoperative opioid prescriptions to a supply of 3 or fewer days is feasible for patients, reduces opioids dispensed, and is associated with conversion to chronic opioid use.

This phase 2 randomized clinical trial evaluates the effect of β-glucan administered during vaccine priming on antibody titer and seroconversion rates at a large cancer center in children with high-risk neuroblastoma.

This randomized clinical trial examines quality of life in patients with resected melanoma at high risk for relapse who were treated with adjuvant pembrolizumab vs standard of care with either ipilimumab or high-dose interferon α 2b.